United Kingdom: Healthcare

The ASA and CAP's Annual Report 2025 reveals a fundamental transformation in UK advertising regulation, with AI-enabled monitoring now scanning nearly 60 million online ads and proactive enforcement overtaking reactive complaints work. From prescription weight-loss medicines to influencer disclosures and green claims, the report exposes critical compliance gaps across multiple sectors while signaling an era of unprecedented data-driven scrutiny.

In a recent LSIPR article published for World Health Day 2026, the spotlight is on the growing momentum in women’s health innovation, and the persistent gaps that still hamper progress.

Global Asbestos Awareness Week has just finished – a reminder that this problem still requires action within the construction industry.

Parental Alcohol Misuse (PAM) remains a significant safeguarding concern across England. Tens of thousands of children live with a parent whose alcohol...

We spend a great deal of time advising private equity sponsors on European real estate transactions from our London office.

On 16 February 2026, the UK's Medicines and Healthcare products Regulatory Agency ("MHRA") opened a public consultation on proposals...

Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs)...

Compliance is never really optional, but this is especially true in healthcare; it's the backbone of patient trust, ethical operations and organizational success.

Following a public consultation, the UK government has outlined plans to publish guidance on disclosing payments made by the medicines and medical devices industries to the healthcare sector.